½ÃÀ庸°í¼
»óÇ°ÄÚµå
1310436
Áö¼Ó±âµµ¾ç¾Ð ±â±â ½ÃÀå : ÇöȲ ºÐ¼®°ú ¿¹Ãø(2022-2030³â)Continuous Positive Airway Pressure Devices Market: Current Analysis and Forecast (2022-2030) |
Áö¼Ó±âµµ¾ç¾Ð(CPAP)Àº ±âµµ¾ç¾Ðȯ±âÀÇ ÀÏÁ¾À̸ç, ´ë±â¾Ðº¸´Ù Å« Á¤»ó¾ÐÀÌ »ç¶÷ÀÇ »ó±âµµ¿¡ Áö¼ÓÀûÀ¸·Î ´õÇØÁý´Ï´Ù. CPAP ½ÃÀåÀÇ ¼ºÀåÀº ´ç´¢º´, °íÇ÷¾Ð, ºñ¸¸, Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ(OSA), È£Èí °ï¶õ°ú °°Àº ÆóÁúȯÀÇ ¼¼°è À¯º´·ü »ó½Â µî ¸î°³ÀÇ ¿äÀο¡ ÀÇÇÑ °ÍÀ¸·Î, CPAP ±â±âÀÇ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¸é ¹Ì±¹ Áúº´¿¹¹æÅëÁ¦¼¾ÅÍÀÇ Çൿ À§Çè ¿äÀÎ °¨½Ã ½Ã½ºÅÛ(BFRSS) 2019¿¡ µû¸£¸é ¹Ì±¹ÀÇ ¼ºÀÎ ºñ¸¸À²Àº 42.4%¿´½À´Ï´Ù. ÀÌ°ÍÀº Àü¹Ì Æò±ÕÀÌ Ã³À½À¸·Î 40%¸¦ ³ÑÀº °ÍÀÔ´Ï´Ù.
Áö¼Ó±âµµ¾ç¾Ð ½ÃÀåÀº ¼ö¸é¹«È£ÈíÁõÈıºÀÇ Áõ·Ê ¼ö³ª °ü·Ã ÁúȯÀÇ Áõ°¡, È£Èí±âÁúȯÀ» ¾Î°í ÀÖ´Â ³ë³â Àα¸ÀÇ ±ÞÁõ¿¡ ÀÇÇØ ¾à 6.4%ÀÇ ¾ÈÁ¤µÈ ¼ºÀåÀÌ Àü¸ÁµË´Ï´Ù. ¶ÇÇÑ ¼¼°è Àα¸ÀÇ °í·ÉÈ´Â ±Þ¼ÓÈ÷ ÁøÇàµÇ°í ÀÖÀ¸¸ç, °í·ÉÀÚ Àα¸¿¡¼ È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÇöÀúÇÑ ¿äÀÎÀÔ´Ï´Ù. ¶ÇÇÑ °í·ÉÀÚ´Â ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä, ¼ö¸é¹«È£ÈíÁõÈıº µîÀÇ È£Èí±âÁúȯ¿¡ ÀÌȯÇϱ⠽¬¿ì¸ç, CPAP ±â±âÀÇ ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù. ¿¹¸¦ µé¸é 2020³â¿¡´Â ¼ºÀÎÀÇ 5.0%¿¡ ÇØ´çÇÏ´Â 1,250¸¸ ¸íÀÌ COPD(¸¸¼ºÆó¼â¼ºÆóÁúȯ, ¸¸¼º ±â°üÁö¿°, Æó±âÁ¾) Áø´ÜÀ» ¹ÞÀº °ÍÀ¸·Î º¸°íµÇ°í ÀÖ½À´Ï´Ù.
ÄÄÆ÷³ÍÆ®º°·Î º¸¸é ½ÃÀåÀº CPAP ¸¶½ºÅ©, CPAP °¡½À±â, ±âŸ·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß CPAP °¡½À±â Ä«Å×°í¸®°¡ 2021³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. CPAP °¡½À±â´Â CPAP ¸Ó½Å¿¡ ÇʼöÀûÀÎ ¾×¼¼¼¸®·Î, CPAP µð¹ÙÀ̽º ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ¼ö¸é¹«È£ÈíÁõÈıºÀ̳ª ±âŸ È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡, CPAP ¿ä¹ýÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀÎÁöµµÀÇ Çâ»ó, ÀûÁ¤ °¡°ÝÀ¸·Î ÈÞ´ë °¡´ÉÇÑ CPAP µð¹ÙÀ̽ºÀÇ ÀÌ¿ë °¡´É¼ºÀÇ Áõ°¡°¡ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀÇ ÀϺÎÀÔ´Ï´Ù.
¿ëµµº°·Î º¸¸é ½ÃÀåÀº ¼ö¸é¹«È£ÈíÁõÈıº°ú COPD·Î ¾çºÐµË´Ï´Ù. ÀÌ Áß ¼ö¸é¹«È£ÈíÁõÈıº Ä«Å×°í¸®´Â °í·ÉÀÚ Àα¸¿¡¼ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõ(OSA) Áõ·ÊÀÇ Áõ°¡ ¹× OSA ¶Ç´Â ±âŸ È£Èí±âÁúȯ¿¡ ´ëÇÑ ÀǽÄÀÇ Çâ»ó¿¡ ÀÇÇØ 2022³â ½ÃÀåÀ» µ¶Á¡ÇÏ°í ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ Áß ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î »ý°¢µË´Ï´Ù. ¿¹¸¦ µé¸é À¯·´ È£Èí±â ÇÐȸ°¡ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é À¯·´ ³ë³â Àα¸ÀÇ ¾à 13.0%-32.0%°¡ ¼ö¸é¹«È£ÈíÁõÈıºÀ» ¾Î°í ÀÖ½À´Ï´Ù.
ÃÖÁ¾»ç¿ëÀÚ¿¡ ±â¹ÝÇÏ¿© ½ÃÀåÀº º´¿ø & Ŭ¸®´Ð, ȨÄɾî, ±âŸ·Î ±¸ºÐµË´Ï´Ù. ÀÌ Áß È¨Äɾî Ä«Å×°í¸®°¡ 2022³â ½ÃÀåÀ» µ¶Á¡Çß½À´Ï´Ù. ÀÌ°ÍÀº ÁÖ·Î ÀÌ ½ÃÀåÀÇ ±â¾÷ÀÌ ÀÌ ÁúȯÀÇ Ä¡·á¸¦ ¹Þ°í ÀÖ´Â »ç¶÷µé »çÀÌ¿¡¼ ÀÚÅÿ¡¼ »ç¿ëÇÒ ¼ö ÀÖ´Â »õ·Î¿î ÈÞ´ë¿ë µð¹ÙÀ̽ºÀÇ ¹ß¸Å¿¡ ÁÖ·ÂÇÏ°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ƯÈ÷ ¹Ì±¹, ¿µ±¹, µ¶ÀÏ, ÀϺ» µîÀÇ ±¹°¡¿¡¼´Â ÀÚÅÿ¡¼ÀÇ OSA Ä¡·á¿¡ ´ëÇÑ ¼±È£µµÀÇ Áõ°¡¿Í ÇÔ²² ȨÄɾ ±âŸ ȯ°æ¿¡¼ ÀÌ ±â±âÀÇ ¼ö¿ä¸¦ ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù.
Áö¼Ó±âµµ¾ç¾Ð »ê¾÷ÀÇ ½ÃÀå µµÀÔ¿¡ °üÇÑ ½ÉÃþ ÀÌÇظ¦ À§ÇØ ½ÃÀåÀº ºÏ¹Ì(¹Ì±¹, ij³ª´Ù, ±âŸ ºÏ¹Ì Áö¿ª), À¯·´(µ¶ÀÏ, ¿µ±¹, ÇÁ¶û½º, ½ºÆäÀÎ, ÀÌÅ»¸®¾Æ, ±âŸ À¯·´ Áö¿ª), ¾Æ½Ã¾ÆÅÂÆò¾ç(Áß±¹, ÀϺ», Àεµ, ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç), ±âŸ ¼¼°è ±¹°¡¿¡¼ ¼¼°èÀÇ Á¸Àç¿¡ ±â¹ÝÇÏ¿© ºÐ¼®µË´Ï´Ù. ºÏ¹Ì´Â ÀÇ·á ÀÎÇÁ¶ó°¡ È®¸³µÇ¾î ÀÖÀ¸¸ç, ±â¼úÀÇ µµÀÔÀÌ ÁøÇàµÇ°í ÀÖ´Â °ÍÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß ¼¼°èÀÇ CPAP ±â±â ½ÃÀåÀ» µ¶Á¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ ÀÌ ±¹°¡¿¡¼´Â ¼ö¸é¹«È£ÈíÁõÈıºÀÇ ºÎ´ãÀÌ Áõ°¡ÇÏ°í ÀÖÀ¸¸ç, ÀÌ°ÍÀÌ CPAP ±â±â ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¸é Sleep Apnea org¿¡ µû¸£¸é 2,200¸¸ ¸íÀÇ ¹Ì±¹ÀÎÀÌ ¼ö¸é¹«È£ÈíÁõÈıºÀ» ¾Î°í ÀÖÀ¸¸ç, Áߵ¡¤ÁßÁõ Æó¼â¼º ¼ö¸é¹«È£ÈíÁõÀÇ 80%°¡ Áø´ÜµÇÁö ¾ÊÀº °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.
Continuous positive airway pressure (CPAP) is a type of positive airway pressure ventilation in which a steady pressure larger than atmospheric pressure is continuously applied to a person's upper respiratory tract. The growth of the CPAP market is attributed due to several factors such as the rising prevalence of diabetes, high blood pressure, obesity, obstructive sleep apnea (OSA), and pulmonary disorders, such as dyspnea globally, which is to higher demand for CPAP devices. For instance, according to the Centers for Disease Control and Prevention's Behavioral Risk Factors Surveillance System (BFRSS) 2019, the adult obesity percentage in the United States was 42.4%. This was the first time the national average surpassed 40%.
The continuous positive airway pressure market is expected to grow at a steady rate of around 6.4% owing to the increasing number of sleep apnea cases and related conditions and the surging geriatric population with respiratory diseases. Moreover, the global population is aging at a rapid pace, leading to an increased prevalence of respiratory diseases among the elderly population which is a prominent factor in the growth of the market. Also, older adults are more susceptible to respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea which will drive the demand for CPAP devices. For instance, in 2020, 12.5 million people, or 5.0% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema.
Based on component, the market is segmented into CPAP masks, CPAP humidifiers, and others. Among them, the CPAP humidifiers category dominated the market in 2021. CPAP humidifiers are an essential accessory for CPAP machines and are driving the growth of the CPAP devices market. The increasing prevalence of sleep apnea and other respiratory disorders, the growing awareness of the benefits of CPAP therapy, and the increasing availability of affordable and portable CPAP devices are some of the key factors contributing to the market's growth.
Based on application, the market is bifurcated into sleep apnea and COPD. Among them, the sleep apnea category dominated the market in 2022 owing to the growing obstructive sleep apnea (OSA) cases in the geriatric population and the rising awareness for OSA or other respiratory diseases will drive the growth of the market during the forecast period. For instance, according to the data published by the European Respiratory Society, approximately 13.0% to 32.0% of the geriatric population in Europe was suffering from sleep apnea.
Based on end-user, the market is segmented into hospitals & clinics, home care, and others. Among them, the home care category dominated the market in 2022. This is mainly due to the players in the market concentrating on launching new, portable devices that can be used at home among those undergoing treatment for the condition. This, along with a growing preference for treating OSA at home, is driving up demand for these devices in-home care and other settings, particularly in countries like the U.S., the U.K., Germany, and Japan, among others.
For a better understanding of the market adoption of the continuous positive airway pressure industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to dominate the global CPAP devices market during the forecast period due to the presence of well-established healthcare infrastructure and higher adoption of technology in the country. Also, the country is witnessing the growing burden of sleep apnea which in turn is facilitating the CPAP devices market growth. For instance, according to sleep apnea org, It is estimated that 22 million Americans suffer from sleep apnea, with 80 percent of the cases of moderate and severe obstructive sleep apnea undiagnosed.
Some of the major players operating in the market include: BMC; ResMed; Fisher & Paykel Healthcare Limited; Drive DeVilbiss Healthcare; Shanghai Fosun Pharmaceutical Group Co., Ltd.; Smiths Group plc; Airing; Koninklijke Philips N.V.; Honeywell International Inc.; and Transcend, Inc.